Business Wire

ThetaRay Appoints Financial Markets Technology Leader Brad Levy as Chief Executive Officer

21.1.2026 17:00:00 CET | Business Wire | Press Release

Share

ThetaRay, a global leader in Cognitive AI financial crime compliance, today announced the appointment of Brad Levy as Chief Executive Officer. Levy, a leading financial markets infrastructure executive and former CEO of Symphony, will lead ThetaRay’s next phase of growth as the company continues to scale its Cognitive AI platform, now emerging as the leading AI strategy and technology for transaction monitoring and transaction due diligence, across banks and fintechs worldwide.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260121002476/en/

ThetaRay Appoints Brad Levy as CEO

Levy brings decades of experience building and leading mission-critical financial infrastructure at scale. Most recently, he served as CEO of Symphony, the financial markets infrastructure and technology platform established by a consortium of leading global banks, including Goldman Sachs and other major financial institutions, and relied upon by hundreds of thousands of financial professionals globally. Prior to Symphony, Levy was a partner and senior executive at IHS Markit, including serving as CEO of MarkitSERV and leading the firm’s global loan settlement and software services business. Earlier in his career, Levy spent 18 years at Goldman Sachs, culminating as Managing Director and Global Head of the firm’s Principal Strategic Investments Group. He has been widely recognized for leadership and innovation across financial services, including being named CEO of the Year at the 2022 Markets Choice Awards.

“ThetaRay has built the leading AI platform for financial crime compliance, with proven impact across the world’s most complex financial environments,” said Brad Levy, incoming CEO of ThetaRay. “The industry is reaching a tipping point, where AI is no longer optional but foundational. My focus is on scaling this platform globally, deepening our partnerships with financial institutions, and embedding compliance as a strategic capability that drives sustainable growth. I’m tremendously excited to lead the company forward alongside a team that combines deep domain expertise with real-world execution.”

Levy joins ThetaRay at a pivotal moment in the company’s evolution. Under outgoing CEO Peter Reynolds, ThetaRay accelerated global growth, expanded its enterprise customer base, and strengthened its end-to-end product suite, further establishing the company as a category leader in Cognitive AI financial crime compliance.

ThetaRay also announced that Reynolds, who has served as Chief Executive Officer since June 2023, will be stepping down from the role due to family reasons and transitioning to an advisory position. He will remain actively involved during a defined transition period and will continue to support the company and its leadership team as an advisor.

“ThetaRay is the clear category leader in Cognitive AI for financial crime compliance, and we have reached a moment where scale, execution, and global impact matter more than ever,” said Erel Margalit, Chairman of ThetaRay and Founder and Chair of JVP. “Brad is a proven leader in building and operating core financial infrastructure at global scale, and he is the right CEO to lead ThetaRay into its next phase as a defining platform for the industry. As Vertical AI becomes a critical driver in transaction monitoring and customer due diligence across the banking and financial sectors, ThetaRay is strengthening its position as a technological leader in this space. Over the coming years, we look forward to translating this leadership into a strong international business footprint. Beyond stopping increasingly sophisticated financial crime, ThetaRay enables legitimate global trade corridors by allowing banks and financial institutions to execute international transactions more efficiently and securely. I also want to thank Peter Reynolds for his leadership and impact. Peter helped in scaling the business to tens of millions of dollars in revenue, and we look ahead to the next phase of growth as we expand to hundreds of millions of dollars across international markets, with Vertical and Cognitive AI emerging as the category of choice for securing monetary transactions.”

ThetaRay is backed by leading global investors, including JVP and Portage, alongside additional strategic investors. Founded in 1993 by Erel Margalit, JVP is one of the pioneering venture capital firms in Israel and New York and has been ranked by Preqin among the world’s top consistently performing VC firms, having built and scaled more than 160 companies and led numerous landmark acquisitions and NASDAQ IPOs, most recently CyberArk, which was sold for $25bn to PaloAlto Networks. Portage is a global fintech-focused investment platform with over $2.5 billion in assets under management, partnering with financial services innovators across stages by providing capital, industry expertise, and access to a global network of investors and commercial partners across North America and Europe as part of the Sagard platform.

About ThetaRay

ThetaRay harnesses the power of Cognitive AI for financial crime compliance, enabling financial institutions to precisely identify legitimate customers while flagging bad actors. The SaaS solutions overcome the limitations of traditional rule-based systems by shortening long implementation lifecycles, enabling efficient, risk-aware compliance operations. By transforming compliance from a regulatory obligation into a driver of growth, ThetaRay allows institutions to scale faster and expand confidently into new markets. By uncovering hidden criminal networks and delivering actionable insights, ThetaRay empowers organizations to combat evolving threats, maintain positive regulator relationships, and enhance customer experiences. Implemented at some of the world’s leading financial institutions including Santander, Clear Bank, Mashreq Bank, Payoneer, Onafriq, and Travelex, ThetaRay helps financial institutions thrive, fostering trust and confidence across the global financial ecosystem.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260121002476/en/

Contacts

Media Contact
pr@thetaray.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye